2021
The impact of self-help groups on successful substance use treatment completion for opioid use: An intersectional analysis of race/ethnicity and sex
Stenersen MR, Thomas K, Struble C, Moore KE, Burke C, McKee S. The impact of self-help groups on successful substance use treatment completion for opioid use: An intersectional analysis of race/ethnicity and sex. Journal Of Substance Use And Addiction Treatment 2021, 136: 108662. PMID: 34840040, PMCID: PMC8940633, DOI: 10.1016/j.jsat.2021.108662.Peer-Reviewed Original ResearchConceptsOpioid useTreatment completionRace/ethnicitySelf-help groupsCompletion of treatmentTreatment Episodes DataSelf-help group participationTreatment outcomesSex disparitiesEpisode dataCurrent studyStimulant useSubstance useSexTreatmentPositive associationHigh rateBlack menEthnicityAssociationMenGroup
2017
Sex disparities in substance abuse research: Evaluating 23 years of structural neuroimaging studies
Lind KE, Gutierrez EJ, Yamamoto DJ, Regner MF, McKee SA, Tanabe J. Sex disparities in substance abuse research: Evaluating 23 years of structural neuroimaging studies. Drug And Alcohol Dependence 2017, 173: 92-98. PMID: 28212516, PMCID: PMC5581940, DOI: 10.1016/j.drugalcdep.2016.12.019.Peer-Reviewed Original ResearchConceptsSubstance use statusSex differencesBrain imaging researchSex disparitiesBrain imaging studiesStructural brain imaging studiesSubstance use studiesSubstance effectsSex effectsBrain morphometric changesStructural neuroimaging studiesSubstance use disordersUse statusNeuroimaging studiesNumber of participantsSubstance abuse researchBrain morphometryStructural brainGreater biasClinical courseSubstance abuseAnalytic approachBrain structuresProportion of studiesImaging research
2015
Sex Differences in Varenicline Efficacy for Smoking Cessation: A Meta-Analysis
McKee SA, Smith PH, Kaufman M, Mazure CM, Weinberger AH. Sex Differences in Varenicline Efficacy for Smoking Cessation: A Meta-Analysis. Nicotine & Tobacco Research 2015, 18: 1002-1011. PMID: 26446070, PMCID: PMC5942618, DOI: 10.1093/ntr/ntv207.Peer-Reviewed Original ResearchConceptsSmoking cessation medicationsCessation medicationsSmoking cessationDouble-blind placebo-controlled trialEfficacy of vareniclinePlacebo-controlled trialShort-term outcomesClinical trial dataSex differencesSimilar ratesWeek 52Week 24Women smokersNicotine replacementWeek 12Outcome endpointsTherapeutic responseClinical trialsContinuous abstinenceVarenicline's efficacyVareniclinePlacebo outcomesEqual efficacySex disparitiesEffective FDA